Business Description
Cytokinetics Inc
NAICS : 325412
SIC : 2834
ISIN : US23282W6057
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.82 | |||||
Equity-to-Asset | -0.49 | |||||
Debt-to-Equity | -1.91 | |||||
Debt-to-EBITDA | -1.65 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -1.47 | |||||
Beneish M-Score | 93.45 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -55.2 | |||||
3-Year EBITDA Growth Rate | -52.1 | |||||
3-Year EPS without NRI Growth Rate | -40.4 | |||||
3-Year FCF Growth Rate | -407.2 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 31.97 | |||||
9-Day RSI | 36.89 | |||||
14-Day RSI | 39.78 | |||||
6-1 Month Momentum % | 123.68 | |||||
12-1 Month Momentum % | 94.29 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.19 | |||||
Quick Ratio | 7.19 | |||||
Cash Ratio | 6.97 | |||||
Days Sales Outstanding | 115.18 | |||||
Days Payable | 19.96 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.7 | |||||
Shareholder Yield % | -3.34 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -8755.86 | |||||
Operating Margin % | -13272.04 | |||||
Net Margin % | -14141.74 | |||||
FCF Margin % | -11171.95 | |||||
ROA % | -65.62 | |||||
ROIC % | -211.31 | |||||
ROC (Joel Greenblatt) % | -305.15 | |||||
ROCE % | -64.53 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1634.21 | |||||
EV-to-EBIT | -14.14 | |||||
EV-to-Forward-EBIT | -13.01 | |||||
EV-to-EBITDA | -14.45 | |||||
EV-to-Forward-EBITDA | -13.18 | |||||
EV-to-Revenue | 1767.09 | |||||
EV-to-Forward-Revenue | 1381.28 | |||||
EV-to-FCF | -15.95 | |||||
Price-to-Median-PS-Value | 41.13 | |||||
Earnings Yield (Greenblatt) % | -7.07 | |||||
FCF Yield % | -6.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cytokinetics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 3.455 | ||
EPS (TTM) (€) | -4.991 | ||
Beta | 1.45 | ||
Volatility % | 160.41 | ||
14-Day RSI | 39.78 | ||
14-Day ATR (€) | 1.606454 | ||
20-Day SMA (€) | 61.4 | ||
12-1 Month Momentum % | 94.29 | ||
52-Week Range (€) | 25 - 103 | ||
Shares Outstanding (Mil) | 104.58 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cytokinetics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cytokinetics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Cytokinetics Inc Frequently Asked Questions
What is Cytokinetics Inc(STU:KK3A)'s stock price today?
When is next earnings date of Cytokinetics Inc(STU:KK3A)?
Does Cytokinetics Inc(STU:KK3A) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |